Follow
Som Mukherjee
Som Mukherjee
Associate Professor, McMaster University
Verified email at hhsc.ca
Title
Cited by
Cited by
Year
Abiraterone in metastatic prostate cancer without previous chemotherapy
CJ Ryan, MR Smith, JS De Bono, A Molina, CJ Logothetis, P De Souza, ...
New England Journal of Medicine 368 (2), 138-148, 2013
28012013
Adjuvant therapy for completely resected stage II colon cancer
A Figueredo, ME Coombes, S Mukherjee
Cochrane Database of Systematic Reviews, 2008
3492008
External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative …
TJ Whelan, JA Julian, TS Berrang, DH Kim, I Germain, AM Nichol, M Akra, ...
The Lancet 394 (10215), 2165-2172, 2019
2042019
Breast cancer chemotherapy induces the release of cell‐free DNA, a novel procoagulant stimulus
LL Swystun, S Mukherjee, PC Liaw
Journal of Thrombosis and Haemostasis 9 (11), 2313-2321, 2011
1672011
Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma …
T Powles, MS van der Heijden, D Castellano, MD Galsky, Y Loriot, ...
The Lancet Oncology 21 (12), 1574-1588, 2020
1632020
Randomized trial of a telephone-based weight loss intervention in postmenopausal women with breast cancer receiving letrozole: the LISA trial
PJ Goodwin, RJ Segal, M Vallis, JA Ligibel, GR Pond, A Robidoux, ...
Journal of clinical oncology 32 (21), 2231-2239, 2014
1562014
Randomized phase II trial of Custirsen (OGX-011) in combination with docetaxel or mitoxantrone as second-line therapy in patients with metastatic castrate-resistant prostate …
F Saad, S Hotte, S North, B Eigl, K Chi, P Czaykowski, L Wood, M Pollak, ...
Clinical Cancer Research 17 (17), 5765-5773, 2011
1382011
Nanoparticle albumin-bound paclitaxel for second-line treatment of metastatic urothelial carcinoma: a single group, multicentre, phase 2 study
YJ Ko, CM Canil, SD Mukherjee, E Winquist, C Elser, A Eisen, ...
The lancet oncology 14 (8), 769-776, 2013
1362013
Effect of metformin vs placebo on weight and metabolic factors in NCIC CTG MA. 32
PJ Goodwin, WR Parulekar, KA Gelmon, LE Shepherd, JA Ligibel, ...
JNCI: Journal of the National Cancer Institute 107 (3), 2015
1242015
A phase II trial of sorafenib in first-line metastatic urothelial cancer: a study of the PMH Phase II Consortium
SS Sridhar, E Winquist, A Eisen, SJ Hotte, E McWhirter, IF Tannock, ...
Investigational new drugs 29 (5), 1045-1049, 2011
972011
A phase I dose-escalation study of apatorsen (OGX-427), an antisense inhibitor targeting heat shock protein 27 (Hsp27), in patients with castration-resistant prostate cancer …
KN Chi, EY Yu, C Jacobs, J Bazov, C Kollmannsberger, CS Higano, ...
Annals of Oncology 27 (6), 1116-1122, 2016
892016
Custirsen in combination with docetaxel and prednisone for patients with metastatic castration-resistant prostate cancer (SYNERGY trial): a phase 3, multicentre, open-label …
KN Chi, CS Higano, B Blumenstein, JM Ferrero, J Reeves, S Feyerabend, ...
The lancet oncology 18 (4), 473-485, 2017
812017
Is red meat intake a risk factor for breast cancer among premenopausal women?
VH Taylor, M Misra, SD Mukherjee
Breast cancer research and treatment 117 (1), 1-8, 2009
792009
Cardiac complications associated with checkpoint inhibition: a systematic review of the literature in an important emerging area
H Mir, M Alhussein, S Alrashidi, H Alzayer, A Alshatti, N Valettas, ...
Canadian Journal of Cardiology 34 (8), 1059-1068, 2018
772018
Improvements in Radiographic Progression-Free Survival Stratified by ERG Gene Status in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Abiraterone …
G Attard, JS De Bono, CJ Logothetis, K Fizazi, SD Mukherjee, AM Joshua, ...
Clinical cancer research 21 (7), 1621-1627, 2015
582015
Physician‐related facilitators and barriers to patient involvement in treatment decision making in early stage breast cancer: perspectives of physicians and patients
MA O’Brien, PM Ellis, TJ Whelan, C Charles, A Gafni, P Lovrics, ...
Health Expectations 16 (4), 373-384, 2013
522013
Safety of continuing trastuzumab despite mild cardiotoxicity: a phase I trial
DP Leong, T Cosman, MM Alhussein, N Kumar Tyagi, S Karampatos, ...
Cardio Oncology 1 (1), 1-10, 2019
482019
Management of small cell carcinoma of the bladder: Consensus guidelines from the Canadian Association of Genitourinary Medical Oncologists (CAGMO)
P Moretto, L Wood, U Emmenegger, N Blais, SD Mukherjee, E Winquist, ...
Canadian Urological Association Journal 7 (1-2), E44, 2013
482013
Cardiovascular risk in men with prostate cancer: insights from the RADICAL PC study
DP Leong, V Fradet, B Shayegan, E Duceppe, R Siemens, T Niazi, L Klotz, ...
The Journal of urology 203 (6), 1109-1116, 2020
462020
Statin therapy in the treatment of active cancer: A systematic review and meta-analysis of randomized controlled trials
MAM Farooqi, N Malhotra, SD Mukherjee, S Sanger, SK Dhesy-Thind, ...
PLoS One 13 (12), e0209486, 2018
462018
The system can't perform the operation now. Try again later.
Articles 1–20